Dexamethasone 12 mg versus 6 mg for patients with COVID-19 and severe hypoxaemia: a pre-planned, secondary Bayesian analysis of the COVID STEROID 2 trial
Research output: Contribution to journal › Journal article › Research › peer-review
| Original language | English |
|---|---|
| Journal | Intensive Care Medicine |
| Volume | 48 |
| Pages (from-to) | 45–55 |
| Number of pages | 11 |
| ISSN | 0342-4642 |
| DOIs | |
| Publication status | Published - 2022 |
- COVID-19, Hypoxaemia, Critical illness, Corticosteroids, Bayesian analysis
Research areas
Links
- https://europepmc.org/articles/pmc8579417?pdf=render
Final published version
ID: 285184313